[ Price : $8.95]
Nucleus RadioPharma appoints former FDA commissioner Stephen Hahn (Trump Administration 2019-2021) as its chief executive officer.[ Price : $8.95]
FDA issues enVVeno Medical a not-approvable letter for its PMA on VenoValve, a surgical replacement venous valve designed to treat...[ Price : $8.95]
FDA lifts a clinical hold on Rocket Pharmaceuticals pivotal Phase 2 trial of RP-A501, an investigational gene therapy for Danon di...[ Price : $8.95]
Experts share varying opinions with Clinical Trials Arena on the impact of an FDA rule barring biotech companies from sending cell...[ Price : $8.95]
Some 750 current and former HHSers call on secretary Robert F. Kennedy, Jr., to protect them and the rest of his staff from attack...[ Price : $8.95]
Updated medical device breakthrough device designation metrics show 1,176 approvals since 2015 and 160 marketing authorizations.[ Price : $8.95]
FDA suggests ways CytoSorbents can proceed with its de novo application for DrugSorb-ATR.[ Price : $8.95]
Wiley Rein petitions FDA to take seven specific actions to address public health risks associated with compounded semaglutide drug...